Abstract:Kinases and transcriptional regulators are fundamental components of cell signaling that are expressed on many types of immune cells which are involved in secretion of cytokines, cell proliferation, differentiation, and apoptosis. Both play important roles in biological responses in health as well as in illnesses such as the autoimmune diseases which comprise at least 80 disorders. These diseases are caused by complex genetic and environmental interactions that lead to a breakage of immunologic tolerance and a disruption of the balance between self-reactive cells and regulatory cells. Kinases or transcriptional regulatory factors often have an abnormal expression in the autoimmune cells that participate in the pathogenesis of autoimmune disease. These abnormally expressed kinases or transcriptional regulators can over-activate the function of self-reactive cells to produce inflammatory cytokines or down-regulate the activity of regulatory cells, thus causing autoimmune diseases. In this review we introduce five kinds of kinase and transcriptional regulator related to autoimmune diseases, namely, members of the Janus kinase (JAK) family (JAK3 and/or tyrosine kinase 2 (TYK2)), fork head box protein 3 (Foxp3), the retinoic acid-related orphan receptor gamma t (RORt), and T-box expressed in T cells (T-bet) factors. We also provide a mechanistic insight into how these kinases and transcriptional regulators affect the function of the immune cells related to autoimmune diseases, as well as a description of a current drug design targeting these kinases and transcriptional regulators. Understanding their exact role helps offer new therapies for control of the inflammatory responses that could lead to clinical improvement of the autoimmune diseases.

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

The JAK/STAT signaling pathway: from bench to clinic

JAK/STAT Signal Transduction: Promising Attractive Targets for Immune, Inflammatory and Hematopoietic Diseases

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression

The JAK-STAT pathway: from structural biology to cytokine engineering

Deciphering JAK/STAT signaling pathway: A multifaceted approach to tumorigenesis, progression and therapeutic interventions

Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders

JAK/STAT signaling pathway in the process of differentiation and maturation of Dendritic calls

Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent

JAK/STAT defects and immune dysregulation, and guiding therapeutic choices

Janus Kinases (jaks): the Efficient Therapeutic Targets for Autoimmune Diseases and Myeloproliferative Disorders.

JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity

Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy

Essential Kinases And Transcriptional Regulators And Their Roles In Autoimmunity

The JAK-STAT pathway at 30: Much learned, much more to do

STATs, promising targets for the treatment of autoimmune and inflammatory diseases

Targeting the JAK-STAT pathway in colorectal cancer: mechanisms, clinical implications, and therapeutic potential

Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?